James M. Fries Rx-360

Jim Fries is a success-based executive with more than 25 years of experience building medical device and diagnostic companies across all pathways, including growth-oriented commercial initiatives, regulatory, and market access. Jim has been involved in driving thought-leader panels and committees within the areas of vascular intervention, cardiometabolics, diabetes, orthopedics, and pharmaceutical quality, which has resulted in numerous guidelines and consensus papers. Jim became CEO of Rx-360 in February of 2018, as a way of fulfilling his personal lifelong commitment to patient safety. Jim's expertise includes:

• Pharmaceutical Supply Chain Security
• Remote Pharmaceutical Auditing
• Managing Pharmaceutical Supply Chain Integrity and Material Quality During a Pandemic (COVID-19)
• Data Integrity
• Joint Audit Program® for the Pharmaceutical Industry
• Utilizing Industry Consortia in Pharma